Treatment of female sexual dysfunction

被引:12
|
作者
Ragucci, KR
Culhane, NS
机构
[1] Med Univ S Carolina, Dept Pharm Practice, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA
[3] Wilkes Univ, Nesbitt Sch Pharm, Dept Pharm Practice, Wilkes Barre, PA 18766 USA
关键词
estrogen; female sexual dysfunction; testosterone;
D O I
10.1345/aph.1C392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder. DATA SOURCES: Articles identified from a MEDLINE search (1 966-June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles. STUDY SELECTION AND DATA EXTRACTION: After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included. DATA SYNTHESIS: FSD is a multicausal and multidimensional problem combining biological, psychological, and interpersonal factors. The American Foundation for Urological Disease classifies FSD into 4 broad categories: sexual desire disorders, arousal disorder, orgasmic disorder, and sexual pain disorders. Depending on specific individual characteristics and category of disorder, a variety of potential treatments are available. Pharmacists can play a role in identifying and managing medication-related adverse effects that may be exacerbating FSD and educating women on treatment modalities. CONCLUSIONS: FSD is a complicated disorder that is often difficult to identify, classify, and treat appropriately. Pharmacists should have an understanding of the potential causes of FSD and the treatment options available so that they may make appropriate recommendations and counsel women effectively.
引用
收藏
页码:546 / 555
页数:10
相关论文
共 50 条
  • [21] Female sexual dysfunction in hypertensive women with or without treatment
    Doumas, M.
    Tsakiris, A.
    Douma, S.
    Papadopoulos, Ang.
    Paraskeuakoul, G.
    Karagianni, A.
    Manali, E.
    Ellinas, C.
    Kanellakopoulou, K.
    Giamarellou, H.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S35 - S35
  • [22] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (02) : 267 - +
  • [23] Female Sexual Dysfunction
    Reed, Michael A.
    [J]. CLINICS IN PLASTIC SURGERY, 2022, 49 (04) : 495 - 504
  • [24] FEMALE SEXUAL DYSFUNCTION
    READ, J
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 1995, 7 (02) : 175 - 182
  • [25] Female sexual dysfunction
    Berman, JR
    Goldstein, I
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (02) : 405 - +
  • [26] Female Sexual Dysfunction
    Lindau, Stacy Tessler
    Abramsohn, Emily
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 134 (01): : E1 - E18
  • [27] Female sexual dysfunction
    Merkatz, RB
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (04): : 331 - 333
  • [28] Female sexual dysfunction
    Goldstein, I
    Graziottin, A
    Heiman, JR
    Johannes, C
    Laan, E
    Levin, RL
    McKenna, KE
    [J]. ERECTILE DYSFUNCTION, 2000, : 509 - 556
  • [29] Female sexual dysfunction
    Korda, J. B.
    [J]. UROLOGE, 2008, 47 (01): : 77 - 89
  • [30] Female sexual dysfunction
    Erdogan Aslan
    Michelle Fynes
    [J]. International Urogynecology Journal, 2008, 19 : 293 - 305